Skip to content
  • Monday, 12 October 2026
  • 8:45 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • NIH Researchers Uncover Intracellular Signaling Mechanisms Explaining GLP-1 Drug Efficacy and Weight Loss Plateaus
Neuroscience & Brain Research

NIH Researchers Uncover Intracellular Signaling Mechanisms Explaining GLP-1 Drug Efficacy and Weight Loss Plateaus

Rifan Muazin Jun 2, 2026 0

The National Institutes of Health (NIH) has released a groundbreaking study detailing the complex intracellular signaling processes triggered by GLP-1…

Read More
Neuroscience & Brain Research

Scientists discover why Ozempic and Wegovy weight loss eventually plateaus

Rifan Muazin May 25, 2026 0

The global landscape of metabolic medicine has been fundamentally altered by the emergence of glucagon-like peptide-1 (GLP-1) receptor agonists. While…

Read More
American Diabetes Association Conference: Groundbreaking GLP-1 Discoveries Eclipsed by Scientific Freedom ProtestInsilico CEO Sees Potentially $2.75 Billion Collaboration as Fusing Lilly’s Clinical Excellence with Insilico’s End-to-End AI EngineScience News A Century of Commitment to Scientific Literacy and Public EngagementScience News: A Century of Empowering Public Understanding of Science
The Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthEliquis Loss of Exclusivity: A Pharmaceutical Patent Cliff of Historic Proportions
2026 PharmSci 360 adds tracks on research credibility and post-animal drug developmentTeva Pharmaceutical Industries Secures FDA Approval for Weltruza, a Once-Monthly Injectable Olanzapine to Transform Schizophrenia CareTWiV 1288: Clinical update with Dr. Daniel Griffin | Microbe TVScientists discover a hidden factor that can make or break chemical reactions
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
2026 PharmSci 360 adds tracks on research credibility and post-animal drug development
Lana Keisha Oct 12, 2026
Pharmaceutical R&D
Teva Pharmaceutical Industries Secures FDA Approval for Weltruza, a Once-Monthly Injectable Olanzapine to Transform Schizophrenia Care
Teuku Ryan Oct 12, 2026
Microbiology & Immunology
TWiV 1288: Clinical update with Dr. Daniel Griffin | Microbe TV
Lina Irawan Oct 12, 2026
Advanced Materials Science
Scientists discover a hidden factor that can make or break chemical reactions
Nila Kartika Wati Oct 12, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ